An experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy has been created.
CORDIS reports two US based biotech companies have been granted ethical permission to attempt to regenerate the brains of people declared clinically dead from TBI.
Roke Manor Research Ltd has developed the world's first threat monitoring system for autonomous vehicles that emulates a mammal's conditioned fear-response mechanism.
Penn Medicine research presented today at the 2012 Alzheimer's Association International Conference shows that an anti-tau treatment called epithilone D (EpoD) was effective in preventing and intervening the progress of Alzheimer's disease in animal models, improving neuron function and cognition, as well as decreasing tau pathology.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
On Oct. 2 at 10 a.m. Pacific (1 p.m. Eastern), Scientific Learning Corp. will present a free, online seminar by Norman Doidge, M.D., author of the New York Times and international bestseller, "The Brain That Changes Itself."
Today the Governor’s Office of Business and Economic Development (GO-Biz) announced the formation of a new Cyber-Health Information Technology Advisory Board as part of an ongoing effort to support cybersecurity innovation and bolster advanced technology industries.
Researchers announced that the UK’s first operation to tackle heart failure with a novel nerve-stimulating device will be performed today. The implantable device operates by stimulating the vagus nerve on the right side of the neck.